GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Net Income From Continuing Operations

OSTX (OS Therapies) Net Income From Continuing Operations : $-7.36 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. OS Therapies's net income from continuing operations for the three months ended in Sep. 2024 was $-2.88 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was $-7.36 Mil.

OS Therapies Net Income From Continuing Operations Historical Data

The historical data trend for OS Therapies's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies Net Income From Continuing Operations Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23
Net Income From Continuing Operations
-7.42 -6.26 -7.79

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.98 -1.47 -1.46 -1.56 -2.88

OS Therapies Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OS Therapies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Net Income From Continuing Operations
Comparable Companies
Traded in Other Exchanges
N/A
Address
15825 Shady Grove Road, Suite 135, Rockville, MD, USA, 20850
Website
https://www.ostherapies.com
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.